Market Place
Sourcing Support
CN Bio, Pharmaron Partner for Global OOC Tech Development
23 Apr 2025 //
BUSINESSWIRE
CN Bio Launches PhysioMimix Assay Kit for Preclinical Toxicology
04 Feb 2025 //
BUSINESSWIRE
CN Bio Partners With Primetech for OOC Solutions in Japan
13 Jan 2025 //
BUSINESSWIRE
CN Bio Launches PhysioMimix Bioavailability Assay Kit: Human 18
14 Nov 2024 //
BUSINESSWIRE
CN Bio Raises $21 Million USD in First Close of Series B Investment Round
23 Apr 2024 //
BUSINESSWIRE
CN Bio & Altis Partner to Develop Next-generation Human Gut/Liver in vitro model
23 Jan 2024 //
BUSINESSWIRE
CN Bio PhysioMimix Organ-on-a-Chip Data Supports Inipharm’s INI-822
04 Dec 2023 //
BUSINESSWIRE
CN Bio Wins ‘Most Impactful Industry Collaboration of the Year’ at OBN Awards
23 Nov 2023 //
BUSINESSWIRE
CN Bio Appoints Deepak Singh as Vice President of Sales and Marketing
14 Mar 2023 //
BUSINESSWIRE
CN Bio launches single-organ higher throughput system PhysioMimix
27 Feb 2023 //
PHARMATIMES
The FDA Further Expands Collaboration With CN Bio to Evaluate the PhysioMimix
17 Jan 2023 //
BUSINESSWIRE
CN Bio appoints Dr Paul Brooks as Chief Executive Officer
19 Dec 2022 //
BUSINESSWIRE
Growing demand for organ-on-a-chip services prompt CN Bio growth
20 Jul 2022 //
FIERCEBIOTECH
CN Bio Opens Laboratory Facilities to Extend Organ-on-a-chip CRS Capabilities
19 Jul 2022 //
BUSINESSWIRE
CN Bio Appoints Dr Paul Brooks as Chief Business Officer
24 May 2022 //
BUSINESSWIRE
CN Bio Enters Research Collaboration with the Infection Innovation Consortium
10 Nov 2021 //
CONTRACTPHARMA
CN Bio inks COVID-19 research deal with iiCON
09 Nov 2021 //
PHARMATIMES
CN Bio and iiCON Announce COVID-19 Research Collaboration
09 Nov 2021 //
BUSINESSWIRE
CN Bio Expands Service Offering to Support Oncology Drug Discovery
05 Oct 2021 //
BIOSPACE
CN Bio Launches Oncology Service
05 Oct 2021 //
CONTRACTPHARMA
CN Bio licenses human gut microbiome modelling tool from MIT
27 Jul 2021 //
PR NEWSWIRE
CN Bio’s PhysioMimix™ Adopted by King’s College London
29 Jun 2021 //
BUSINESSWIRE
CN Bio receives UK government grant to develop single and multi-organ models
02 Mar 2021 //
PHARMAFILE
CN Bio Awarded Innovate UK Grant to Develop Single and Multi-organ Models
01 Mar 2021 //
BUSINESSWIRE
CN Bio and the University of Melbourne Collaborate to Advance Therapies
15 Dec 2020 //
BUSINESSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.